Category - Pharma Industry News
Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer
FDA delays BMS’ liso-cel decision, citing COVID-19 travel restrictions
Amazon launches online pharmacy in the US
Sosei Heptares’ COVID-19 programme advances promising molecules
Alnylam’s RNAi therapeutic Oxlumo gets EU green light
Novartis secures rights to Mesoblast’s remestemcel-L for ARDS
Healthineers’ COVID-19 antibody test launches in EU
UPDATED: BMS completes $13.1bn acquisition of MyoKardia